SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004481
Filing Date
2019-05-08
Accepted
2019-05-08 16:32:39
Documents
80
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20190331x10q.htm 10-Q 2023940
2 EX-10.3 ptgx-20190331ex1035be89e.htm EX-10.3 28711
3 EX-10.4 ptgx-20190331ex10415180f.htm EX-10.4 55657
4 EX-31.1 ptgx-20190331ex31104c29b.htm EX-31.1 12112
5 EX-32.1 ptgx-20190331ex321b5386d.htm EX-32.1 9271
6 GRAPHIC ptgx20190331ex10415180f001.jpg GRAPHIC 656
7 GRAPHIC ptgx20190331ex10415180f002.jpg GRAPHIC 647
8 GRAPHIC ptgx20190331ex10415180f003.jpg GRAPHIC 655
9 GRAPHIC ptgx20190331x10q001.jpg GRAPHIC 57595
  Complete submission text file 0001558370-19-004481.txt   7911912

Data Files

Seq Description Document Type Size
10 EX-101.INS ptgx-20190331.xml EX-101.INS 1745293
11 EX-101.SCH ptgx-20190331.xsd EX-101.SCH 53095
12 EX-101.CAL ptgx-20190331_cal.xml EX-101.CAL 58950
13 EX-101.DEF ptgx-20190331_def.xml EX-101.DEF 175144
14 EX-101.LAB ptgx-20190331_lab.xml EX-101.LAB 442275
15 EX-101.PRE ptgx-20190331_pre.xml EX-101.PRE 383946
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 19807111
SIC: 2834 Pharmaceutical Preparations